About NETRI
NETRI is a company based in Lyon (France) founded in 2018 by Florian Larramendy and Thibault Honegger. NETRI has raised $8.89 million across 2 funding rounds from investors including Bpifrance, Neovacs and Polygone. NETRI offers products and services including Organs-on-Chip Kits, Licensing Programs, and NeuroFluidics Devices. NETRI operates in a competitive market with competitors including Emulate, CN Bio, AxoSim, Mimetas and Obatala Sciences, among others.
- Total Equity Funding$8.89M (USD)
in 2 rounds
- InvestorsBpifrance
& 4 more
Products & Services of NETRI
NETRI offers a comprehensive portfolio of products and services, including Organs-on-Chip Kits, Licensing Programs, and NeuroFluidics Devices.
Kits for in-house platforms to culture and analyze cells.
Programs for technology transfer and internal assays.
Devices for 2D and 3D cell culture and data recording.
Apps and channels of NETRI
its YouTube channel NETRI has 187 subscribers and 30 videos.
Videos from NETRI
The most watched videos on NETRI's YouTube channel, NETRI (187 subscribers). Click a video to play it here.
More on NETRI.
Funding Insights of NETRI
NETRI has successfully raised a total of $8.89M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $8.89M
- Total Rounds 2
- First Round $8.89M
(Mar 2022)
- Investors Count 5
All 2 funding rounds of NETRI with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
5 investors in total: 5 institutional.
Investors in NETRI
NETRI has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Bpifrance, Neovacs and Polygone.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | altanainvestissements.tcc.mode | - | |
Offers rental and sale of residential properties across French departments. | 1952 | polygone-sa.fr | Aurillac, France | |
Offers domain name registration and hosting services for businesses. | 2003 | netangels.ru | Yekaterinburg, Russia | |
Vaccine manufacturing services are provided by Neovacs CDMO. | 1993 | neovacs.com | Paris, France | |
Corporate consultancy, advisory, and funding services are provided to businesses. | 2012 | bpifrance.com | Maisons Alfort, France |
Investor details for NETRI
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of NETRI
23 people are tracked at NETRI (6 in leadership, 17 in team).
| Name | Role | Group |
|---|---|---|
Florian Larramendy | Co-Founder | Leadership |
Thibault Honegger | Co-Founder & CEO | Leadership |
Alexandre Guichard | Head Of Strategic Partnerships | Leadership |
Serge Roux | Equipment Director & Chief Designer | Leadership |
Mélanie Gleyzes | Operation Director | Leadership |
Robert Tep | Director Customer Medical And Scientific Operations | Leadership |
Aurélie Batut | Technicienne | Team |
Thomas Bessy | Spécialiste Scientifique | Team |
Héloïse Castiglione | Doctorante - Netri / Celltechs (sup'biotech/cea) | Team |
Helene Gautier | Research And Development Scientist | Team |
Quentin Hélie | Ingénieur Méthodes Et Industrialisation Puces Microfluidiques | Team |
Camille Baquerre | R&d Engineer | Team |
Johan Renault | Ingénieur R&d - Microfluidique | Team |
Louise Miny | Phd Student | Team |
Benoît Maisonneuve - | Product Owner Clinical Translation | Team |
Myriam Cornet | DRH | Team |
Joan Vincon | Financial And Administrative Officer | Team |
Naina Mishal Tarar | Field Application Scientist | Team |
Laura Ejarque | Responsable Marketing Et Communciation | Team |
Nassiba Bagdadi | Pmo, Business Developer | Team |
3 more people are available in the full profile.
Complete people profiles for NETRI
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of NETRI
3 dated milestones of NETRI across 7 years, from founding to its latest funding, stage changes and deals.
- Founded NETRI is founded.
- Funding First funding round of $8.9M.
- Funding Latest funding round, Series A,.
Competitors of NETRI
NETRI operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Emulate, CN Bio, AxoSim, Mimetas and Obatala Sciences, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| emulatebio.com | 2013 | Boston, United States | $204.49M | 93 | Developer of in vitro models for drug development | |
| cn-bio.com | 2009 | Cambridge, United Kingdom | $44.78M | 33 | Organ-on-a-chip platforms are developed for drug discovery applications. | |
| axosim.com | 2014 | New Orleans, United States | $6.78M | 27 | Nerve-on-a-chip technology is advanced by AxoSim for drug development improvement. | |
| mimetas.com | 2013 | Leiden, Netherlands | $28.9M | – | Microfluidics-based organ-on-a-chip models for drug evaluation are developed. | |
| obatalasciences.com | 2017 | New Orleans, United States | $3.54M | 10 | Provider of research enabling products and services to research centers | |
| nortisbio.com | 2007 | Woodinville, United States | $10.66M | 19 | Small human tissue segments are generated in microfluidic chips. | |
| mepsgen.com | 2019 | Seoul, South Korea | $29.26M | – | Developer of human organ model chips for pharmaceutical development | |
| hesperosinc.com | 2015 | Orlando, United States | – | 15 | Organ-on-a-chip solutions for preclinical testing are developed. | |
| tissuse.com | 2010 | Berlin, Germany | – | 31 | Multi-organ chip platform for tissue culture is developed. |
Detailed competitors of NETRI
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of NETRI
The website of NETRI (netri.com) receives about 2.3K visits a month.
- Monthly visits2.3K
▲ 23.2% vs previous month
Websites whose visitors overlap most with NETRI. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
biovalley-france.com | biovalley-france.com | 100% | – | #3,862,373 | – |
lyondecideurs.com | lyondecideurs.com | 99% | – | #1,483,093 | – |
Latest news on Netri
Complete news archive for NETRI
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to NETRI
10 companies that operate in the same segment as NETRI (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about NETRI
NETRI was founded in 2018 and raised its 1st funding round 4 years after it was founded.
NETRI is headquartered in Lyon, France. It is registered at Lyon, Auvergne-rhone-alpes, France.
Thibault Honegger is the current CEO of NETRI. They have also founded this company.
NETRI is a funded company, having raised a total of $8.89M across 2 funding rounds to date. The company's 1st funding round was a Series A of $8.89M, raised on Mar 2022.
NETRI was founded in 2018 in Lyon, France, as a developer of microfluidic devices targeted at industrial applications. The companys NeoBento platform is utilized to create next-generation 3D brain-on-a-chip models, which support research into treatments for neurological diseases. Operations are centered in the biotechnology sector, with a focus on advancing in vitro modeling techniques for pharmaceutical and medical applications. Co-founders include Florian Larramendy and Thibault Honegger, who serves as CEO.
NETRI offers Organs-on-Chip Kits, Licensing Programs, and NeuroFluidics Devices.